GICS Sector : Healthcare
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States.The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.The company was incorporated in 2017 and is based in Fort Myers, Florida. Show Full description
Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.
American Oncology Network Presents 15 Research Abstracts at ASCO Quality 2025
Oct -10
American Oncology Network Reports Strong Growth and Record Milestones in 2025
Aug -12
American Oncology Network Expands Arkansas Presence, Adds Conway Hematology Oncology to National Network
Aug -05
American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists
Jul -24
Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
May -14
American Oncology Network Appoints Terri Casey as Chief Human Resources Officer
May -13
MidAmerica Cancer Care Opens New Medical Oncology Clinic in Kansas City, Kansas
Apr -02
American Oncology: A Buy Rating For Bold Growth Investors
Mar -29
Increasing cancer prevalence, aging population, and advancements in cancer treatments drive growth in comprehensive cancer care services, including medical oncology, hematology, and infusion therapy.
The 'Other' segment of American Oncology Network, Inc. is expected to grow driven by increasing administrative costs, expansion of business operations, and investments in technology infrastructure to support growing patient volumes.
Comprehensive practice management solutions for oncology practices, including billing, scheduling, and electronic health records.
Expert revenue cycle management services, including coding, billing, and claims management, to optimize revenue and reduce bad debt.
Comprehensive clinical trials management solutions, including trial matching, patient recruitment, and data management.
Specialized pharmacy services, including dispensing, inventory management, and patient support, for oncology practices.
Advanced data analytics and insights solutions, providing actionable intelligence for oncology practices to inform clinical and business decisions.
Comprehensive practice operations support, including human resources, finance, and compliance, for oncology practices.
The threat of substitutes is moderate for American Oncology Network, Inc. due to the presence of alternative cancer treatment options, but the company's specialized services and strong network of oncologists mitigate this threat.
The bargaining power of customers is low for American Oncology Network, Inc. as patients often rely on the company's specialized services and have limited negotiating power.
The bargaining power of suppliers is moderate for American Oncology Network, Inc. as the company relies on a network of suppliers for medical equipment and pharmaceuticals, but has some flexibility in negotiating prices.
The threat of new entrants is low for American Oncology Network, Inc. due to the high barriers to entry in the oncology market, including regulatory hurdles and the need for specialized expertise.
The intensity of rivalry is high for American Oncology Network, Inc. due to the competitive nature of the oncology market, with multiple players competing for market share.
| Value | |
|---|---|
| Debt Weight | -384.18% |
| Debt Cost | 4.97% |
| Equity Weight | 484.18% |
| Equity Cost | 6.37% |
| WACC | 11.76% |
| Leverage | -79.35% |
Value: 9.8
Growth: 4.4
Quality: 2.9
Yield: 0.0
Momentum: 10.0
Volatility: 0.7
1-Year Total Return ->
Value: 9.4
Growth: 3.2
Quality: 4.4
Yield: 0.0
Momentum: 10.0
Volatility: 0.7
1-Year Total Return ->
Value: 9.8
Growth: 8.3
Quality: 4.4
Yield: 0.0
Momentum: 0.0
Volatility: 2.0
1-Year Total Return ->
Value: 3.6
Growth: 4.2
Quality: 2.8
Yield: 0.0
Momentum: 10.0
Volatility: 0.7
1-Year Total Return ->
Value: 10.0
Growth: 2.7
Quality: 5.8
Yield: 0.0
Momentum: 1.0
Volatility: 1.7
1-Year Total Return ->
Value: 4.8
Growth: 3.2
Quality: 3.4
Yield: 0.0
Momentum: 2.5
Volatility: 2.0
1-Year Total Return ->